Neumora Therapeutics Inc

NAS:NMRA (USA)  
$ 9.94 +0.18 (+1.84%) 12:09 AM EST
At Loss
P/B:
4.97
Volume:
450.99K
Avg Vol (2M):
1.17M
Trade In:
Volume:
450.99K
At Loss
Avg Vol (2M):
1.17M

Business Description

Neumora Therapeutics Inc
NAICS : 541714 SIC : 2833
ISIN : US6409791000
Description
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.
Name Current Vs Industry Vs History
Cash-To-Debt 124.34
Equity-to-Asset 0.91
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 42.37
9-Day RSI 36.59
14-Day RSI 37.46
6-1 Month Momentum % 23.34
12-1 Month Momentum % -3.3

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.98
Quick Ratio 10.98
Cash Ratio 10.75

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.5
Shareholder Yield % 0.2
Name Current Vs Industry Vs History
ROE % -69.65
ROA % -65.32
ROIC % -1359.56
ROC (Joel Greenblatt) % -4287.35
ROCE % -74.38

Financials (Next Earnings Date:2025-03-07 Est.)

NMRA's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NMRA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Neumora Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.845
Beta 0
Volatility % 76.57
14-Day RSI 37.46
14-Day ATR ($) 0.782535
20-Day SMA ($) 11.01875
12-1 Month Momentum % -3.3
52-Week Range ($) 8.33 - 21
Shares Outstanding (Mil) 161.56

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Neumora Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Neumora Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Neumora Therapeutics Inc Frequently Asked Questions

What is Neumora Therapeutics Inc(NMRA)'s stock price today?
The current price of NMRA is $9.94. The 52 week high of NMRA is $21.00 and 52 week low is $8.33.
When is next earnings date of Neumora Therapeutics Inc(NMRA)?
The next earnings date of Neumora Therapeutics Inc(NMRA) is 2025-03-07 Est..
Does Neumora Therapeutics Inc(NMRA) pay dividends? If so, how much?
Neumora Therapeutics Inc(NMRA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1